BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 12387035)

  • 21. [Drug therapy in subjects with impaired glucose tolerance].
    Kawamori R; Yoshii H
    Nihon Rinsho; 1996 Oct; 54(10):2750-3. PubMed ID: 8914439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combination therapy with insulin and alpha-glucosidase inhibitor].
    Watanabe K; Kawamori R
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():447-51. PubMed ID: 12387032
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.
    Bressler R; Johnson DG
    Arch Intern Med; 1997 Apr; 157(8):836-48. PubMed ID: 9129543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using dose-response characteristics of therapeutics agents for treatment decisions in type 2 diabetes.
    Garber AJ
    Diabetes Obes Metab; 2000 Jun; 2(3):139-47. PubMed ID: 11220549
    [No Abstract]   [Full Text] [Related]  

  • 25. A miracle of salamization: positive divided by two equals negative.
    Iwamoto Y
    Diabet Med; 1997 Nov; 14(11):994. PubMed ID: 9400931
    [No Abstract]   [Full Text] [Related]  

  • 26. Oral pharmacologic management of type 2 diabetes.
    Riddle MC
    Am Fam Physician; 1999 Dec; 60(9):2613-20. PubMed ID: 10605995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of voglibose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].
    Nakamura J
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():457-61. PubMed ID: 15779422
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacological treatment of postprandial hyperglycemia in hypertensive patients with type 2 diabetes mellitus].
    Yamada K
    Nihon Rinsho; 2003 Jul; 61(7):1219-23. PubMed ID: 12877088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
    Inzucchi SE
    JAMA; 2002 Jan; 287(3):360-72. PubMed ID: 11790216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effect of long-term combined treatment with voglibose and pioglitazone on pancreatic islet function of genetically diabetic GK rats.
    Ishida H; Kato S; Nishimura M; Mizuno N; Fujimoto S; Mukai E; Kajikawa M; Yamada Y; Odaka H; Ikeda H; Seino Y
    Horm Metab Res; 1998 Nov; 30(11):673-8. PubMed ID: 9918384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of changeover from voglibose to acarbose on postprandial triglycerides in type 2 diabetes mellitus patients.
    Matsumura M; Monden T; Miyashita Y; Kawagoe Y; Shimizu H; Nakatani Y; Domeki N; Yanagi K; Ikeda S; Kasai K
    Adv Ther; 2009 Jun; 26(6):660-6. PubMed ID: 19568704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure?
    Nagai Y; Hayakawa T; Abe T; Nomura G
    Diabetes Care; 2000 Nov; 23(11):1703. PubMed ID: 11092296
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of troglitazone in patients with type 2 diabetes mellitus not adequately controlled by sulfonylureas.
    Bunnag P; Puavilai G; Chanprasertyotin S; Chandraprasert S; Suwanwalaikorn S; Suthijumroon A; Benjasuratwong Y; Boonyavarakul A; Nitiyanant W; Sriussadaporn S; Deerochanawong C;
    Diabetes Res Clin Pract; 2001 Feb; 51(2):151-3. PubMed ID: 11253769
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacotherapy of type 2 diabetes mellitus.
    Rendell MS; Kirchain WR
    Ann Pharmacother; 2000; 34(7-8):878-95. PubMed ID: 10928401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Troglitazone combination therapy in obese type 2 diabetic patients poorly controlled with alpha-glucosidase inhibitors.
    Bando Y; Ushiogi Y; Okafuji K; Toya D; Tanaka N; Fujisawa M
    J Int Med Res; 1999; 27(2):53-64. PubMed ID: 10446691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase of lipoprotein (a) with troglitazone.
    Matsumoto K; Miyake S; Yano M; Ueki Y; Tominaga Y
    Lancet; 1997 Dec; 350(9093):1748-9. PubMed ID: 9413470
    [No Abstract]   [Full Text] [Related]  

  • 37. Managing type 2 diabetes. A look at the newer agents.
    Larmore SS
    JAAPA; 1999 Jun; 12(6):47-8, 51-4, 57. PubMed ID: 10728087
    [No Abstract]   [Full Text] [Related]  

  • 38. [Troglitazone].
    Yamanouchi T
    Nihon Rinsho; 2000 Feb; 58(2):389-94. PubMed ID: 10707563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes mellitus. Medication update.
    Slagle M
    South Med J; 2002 Jan; 95(1):50-5. PubMed ID: 11827245
    [No Abstract]   [Full Text] [Related]  

  • 40. Seeking sweet relief for diabetes.
    Dove A
    Nat Biotechnol; 2002 Oct; 20(10):977-81. PubMed ID: 12355109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.